Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • lupin

    Tag: lupin

    You Searched For "lupin"
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 6:46 AM GMT
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been reco...
    Lupin to focus on launch of biosimilar, inhalation product in US this fiscal

    Lupin to focus on launch of biosimilar, inhalation product in US this fiscal

    Medical Dialogues Bureau15 July 2019 4:15 AM GMT
    Coupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they add...
    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

    Medical Dialogues Bureau10 July 2019 4:30 AM GMT
    Lupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec T...
    NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details

    NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details

    Farhat Nasim4 July 2019 9:10 AM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

    Medical Dialogues Bureau4 July 2019 4:15 AM GMT
    Cinacalcet tablets are a generic version of Amgen Inc's Sensipar tablets in the same strengths, said Lupin.New Delhi: Drug firm Lupin on Wednesday...
    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Meghna A Singhania23 Jun 2019 11:27 AM GMT
    New Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department ...
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 6:14 AM GMT
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority ...
    Sun pharma, Dr Reddys, others deny allegations of price fixing in US

    Sun pharma, Dr Reddys, others deny allegations of price fixing in US

    Garima16 May 2019 4:05 AM GMT
    In separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and st...
    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Farhat Nasim14 May 2019 11:27 AM GMT
    Mumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Farhat Nasim6 May 2019 4:30 AM GMT
    Lupin Somerset is recalling 46,700 bottles of Morphine Sulfate extended-release tablets in various strengths due to 'failed impurities/degradation spec...
    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Meghna A Singhania3 May 2019 8:20 AM GMT
    Mumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Farhat Nasim1 April 2019 4:20 AM GMT
    Aurobindo Pharma is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.New Delhi:...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 27 May 2022 6:45 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X